Harrow Health (HROW) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Harrow Health Revenue Highlights

Latest Revenue (Y)

$272.30M

Latest Revenue (Q)

$71.64M

Main Segment (Y)

Product Sales Net

Harrow Health Revenue by Period

Harrow Health Revenue by Year

Date	Revenue	Change
2025-12-31	$272.30M	36.41%
2024-12-31	$199.61M	53.32%
2023-12-31	$130.19M	46.95%
2022-12-31	$88.59M	22.24%
2021-12-31	$72.48M	48.30%
2020-12-31	$48.87M	-4.48%
2019-12-31	$51.16M	23.67%
2018-12-31	$41.37M	54.52%
2017-12-31	$26.77M	34.26%
2016-12-31	$19.94M	105.25%
2015-12-31	$9.72M	485.30%
2014-12-31	$1.66M	16500.00%
2013-12-31	$10.00K	-90.00%
2012-12-31	$100.00K	100.00%
2011-12-31	-	100.00%
2010-12-31	-	100.00%
2009-12-31	-	100.00%
2008-12-31	-	100.00%
2007-12-31	-	100.00%
2006-12-31	-	100.00%
2005-12-31	-	-

Harrow Health generated $272.30M in revenue during NA 2025, up 36.41% compared to the previous quarter, and up 557.19% compared to the same period a year ago.

Harrow Health Revenue by Quarter

Date	Revenue	Change
2025-09-30	$71.64M	12.39%
2025-06-30	$63.74M	33.27%
2025-03-31	$47.83M	-28.43%
2024-12-31	$66.83M	35.68%
2024-09-30	$49.26M	0.65%
2024-06-30	$48.94M	41.50%
2024-03-31	$34.59M	-4.86%
2023-12-31	$36.35M	6.10%
2023-09-30	$34.27M	2.38%
2023-06-30	$33.47M	28.22%
2023-03-31	$26.10M	28.40%
2022-12-31	$20.33M	-10.93%
2022-09-30	$22.82M	-2.14%
2022-06-30	$23.32M	5.44%
2022-03-31	$22.12M	9.57%
2021-12-31	$20.19M	7.89%
2021-09-30	$18.71M	3.18%
2021-06-30	$18.13M	17.43%
2021-03-31	$15.44M	5.81%
2020-12-31	$14.60M	1.36%
2020-09-30	$14.40M	78.65%
2020-06-30	$8.06M	-31.79%
2020-03-31	$11.82M	-6.24%
2019-12-31	$12.60M	-1.18%
2019-09-30	$12.76M	-5.63%
2019-06-30	$13.52M	9.98%
2019-03-31	$12.29M	7.96%
2018-12-31	$11.38M	6.01%
2018-09-30	$10.74M	3.42%
2018-06-30	$10.38M	17.13%
2018-03-31	$8.87M	20.83%
2017-12-31	$7.34M	13.17%
2017-09-30	$6.48M	-5.45%
2017-06-30	$6.86M	12.47%
2017-03-31	$6.10M	5.25%
2016-12-31	$5.79M	19.17%
2016-09-30	$4.86M	-0.94%
2016-06-30	$4.91M	12.01%
2016-03-31	$4.38M	25.06%
2015-12-31	$3.50M	30.56%
2015-09-30	$2.68M	36.40%
2015-06-30	$1.97M	25.85%
2015-03-31	$1.56M	184.13%
2014-12-31	$550.11K	24.73%
2014-09-30	$441.03K	-33.95%
2014-06-30	$667.70K	47254.68%
2014-03-31	$1.41K	-43.60%
2013-12-31	$2.50K	-
2013-09-30	$2.50K	-
2013-06-30	$2.50K	-
2013-03-31	$2.50K	100.00%
2012-12-31	-	100.00%
2012-09-30	-	100.00%
2012-06-30	-	-100.00%
2012-03-31	$100.00K	100.00%
2011-12-31	-	100.00%
2011-09-30	-	100.00%
2011-06-30	-	100.00%
2011-03-31	-	100.00%
2010-12-31	-	100.00%
2010-09-30	-	100.00%
2010-06-30	-	100.00%
2010-03-31	-	100.00%
2009-12-31	-	100.00%
2009-09-30	-	100.00%
2009-06-30	-	100.00%
2009-03-31	-	100.00%
2008-12-31	-	100.00%
2008-09-30	-	100.00%
2008-06-30	-	100.00%
2008-03-31	-	100.00%
2007-12-31	-	-

Harrow Health generated $71.64M in revenue during Q3 2025, up 12.39% compared to the previous quarter, and up 146.38% compared to the same period a year ago.

Harrow Health Revenue Breakdown

Harrow Health Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 25	Dec 24	Dec 22	Dec 21	Dec 20
Other Revenues	$394.00K	$5.07M	$3.37M	$392.00K	-
Product Sales Net	$271.91M	-	-	-	-
Other Revenue	-	$915.00K	-	-	-

Harrow Health's latest annual revenue breakdown by segment (product or service), as of Dec 25: Product Sales Net (99.86%), and Other Revenues (0.14%).

Quarterly Revenue by Product

Product/Service	Jun 25	Mar 25	Dec 24	Sep 24	Mar 24	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Other Products	$5.21M	$956.00K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Revenue	$85.00K	$86.00K	$687.00K	$228.00K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Revenues	-	-	-	-	$79.00K	$3.93M	$5.65M	$238.00K	$1.25M	$1.80M	$1.78M	$1.14M	$837.00K	$495.00K	$360.00K	$14.00K	-	-	-	-
License Revenues	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$11.00K	$7.00K	$7.00K	$7.00K

Harrow Health's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Other Products (98.40%), and Other Revenue (1.60%).

Harrow Health Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
TLRY	Tilray Brands	$821.31M	$217.51M
EVO	Evotec SE	$781.43M	$208.73M
COLL	Collegium Pharmaceutical	$780.57M	$209.36M
AMPH	Amphastar Pharmaceuticals	$719.89M	$191.84M
PHR	Phreesia	$419.81M	$120.33M
DVAX	Dynavax	$277.25M	$95.44M
HROW	Harrow Health	$272.30M	$71.64M
BLFS	BioLife Solutions	$96.21M	$25.42M
ALVO	Alvotech	$91.43M	$12.43M
KMTS	KESTRA MEDICAL	$27.81M	$22.57M
TRVI	Trevi Therapeutics	-	-

HROW Revenue FAQ

What is Harrow Health’s yearly revenue?

Harrow Health's yearly revenue for 2025 was $272.3M, representing an increase of 36.41% compared to 2024. The company's yearly revenue for 2024 was $199.61M, representing an increase of 53.32% compared to 2023. HROW's yearly revenue for 2023 was $130.19M, representing an increase of 46.95% compared to 2022.

What is Harrow Health’s quarterly revenue?

Harrow Health's quarterly revenue for Q3 2025 was $71.64M, a 12.39% increase from the previous quarter (Q2 2025), and a 45.44% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $63.74M, a 33.27% increase from the previous quarter (Q1 2025), and a 30.25% increase year-over-year (Q2 2024). HROW's quarterly revenue for Q1 2025 was $47.83M, a -28.43% decrease from the previous quarter (Q4 2024), and a 38.29% increase year-over-year (Q1 2024).

What is Harrow Health’s revenue growth rate?

Harrow Health's revenue growth rate for the last 3 years (2023-2025) was 109.15%, and for the last 5 years (2021-2025) was 275.71%.

What are Harrow Health’s revenue streams?

Harrow Health's revenue streams in c 25 are Other Revenues, and Product Sales Net. Other Revenues generated $394K in revenue, accounting 0.14% of the company's total revenue, down -92.23% year-over-year. Product Sales Net generated $271.91M in revenue, accounting 99.86% of the company's total revenue

What is Harrow Health’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Harrow Health was Product Sales Net. This segment made a revenue of $271.91M, representing 99.86% of the company's total revenue.